Companies › NCEL
NEWCELX LTD (NCEL)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001783036 · EDGAR filings · Updated 2026-07-15
NEWCELX LTD (NCEL) has 4 institutional managers reporting positions valued at $1.77K per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-15 — Foreign issuer report (6-K) filed
- 2026-07-08 — Foreign issuer report (6-K) filed
- 2026-07-01 — Foreign issuer report (6-K) filed
- 2026-06-30 — Foreign issuer report (6-K) filed
- 2026-06-17 — EFFECT filed
- 2026-06-15 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, NEWCELX LTD has 4 institutional holders.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
VIREO GROWTH INC (VREOF) · Kaya Holdings, Inc. (KAYS) · PREMIER AIR CHARTER HOLDINGS INC (PREM) · ABPRO HLDGS INC (ABPO) · VASO CORPORATION (VASO) · BIONEXUS GENE LAB CORP (BGLC)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.